IP Library › Granted Patent US 12,049,095
Granted Patent B2
US 12,049,095 · App. 17/624,146 · Granted Jul 30, 2024

Antimicrobial medical glove printing method

Inventors: Paul Wight (Manchester, GB); Robert Gros (Cambridge, GB)
Assignee: BMG (British Medical Group) Limited
B41M5/0088B41M5/0023B41M5/0047B41M1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,049,095
App. No.
17/624,146
Granted
Jul 30, 2024
Kind
B2
Abstract

A printing process for printing with ink an image on an antimicrobial medical glove formed by a dipping process, wherein the image is first printed on a former and transferred to the glove during dipping.

Claims (19)

1. An ink jet printing process for printing with ink an image on a glove formed by a dipping process, wherein the image is first printed on a former and transferred to the glove during dipping, wherein the film covering the former absorbs the ink on the former.

2. The printing process according to claim 1 , wherein the ink is an aqueous ink comprising anionic dyes, optionally food dyes.

3. The printing process according to claim 1 , wherein the ink is an aqueous ink comprising cationic dyes.

4. The printing process according to claim 1 , wherein the ink is an aqueous ink comprising pigment colorants.

5. The printing process according to claim 4 , wherein the ink comprises any of Pigment Blue 15.3 or 15.4, Pigment Red 122, Pigment Red 146, Pigment Red 147, Pigment Red 202, Pigment Violet 19, Pigment Yellow 155, Pigment Yellow 74A, Pigment Black 7 or Titanium dioxide.

6. The printing process according to claim 1 , wherein the ink is an aqueous ink comprising latex.

7. The printing process according to claim 6 , wherein the ink is an aqueous ink comprising synthetic latexes.

8. The printing process according to claim 1 , wherein the ink is a solvent based ink comprising pigments.

9. The printing process according to claim 1 , wherein the ink is a solvent based ink comprising pigments and PVC.

10. The printing process according to claim 1 , wherein the ink is solvent based, comprising either solvent soluble dyes or pigment dispersions.

11. The printing process according to claim 1 , wherein the ink is an aqueous ink comprising any of antistatic coatings, biocides, or magnetic materials to be deposited onto the surface of a glove formed by dipping.

12. A printing process according to claim 1 , wherein the glove comprises nitrile, natural rubber latex, vinyl, isoprene or neoprene.

13. A printing process according to claim 1 , wherein the former is coated with a coagulant.

14. The printing process according to claim 13 , wherein the coagulant comprises calcium nitrate.

15. The printing process according to claim 13 , wherein the former is dipped in coagulant solution comprising calcium nitrate and calcium stearate.

16. The printing process according to claim 1 , wherein the glove is an antimicrobial glove.

17. An antimicrobial glove obtainable by the process according claim 1 .

18. A printing process according to claim 1 , wherein the ink is an aqueous ink comprising nitrile latex, natural rubber latex, neoprene or isoprene.

19. A printing process according to claim 1 , wherein the ink is an alcohol based ink, comprising either solvent soluble dyes or pigment dispersions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2022
From: CHEMICAL INTELLIGENCE LIMITED
To: BMG (BRITISH MEDICAL GROUP) LIMITED
Reel/Frame 059982/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2022
From: WIGHT, PAUL; GROS, ROBERT
To: CHEMICAL INTELLIGENCE LIMITED
Reel/Frame 059366/0935 →
Priority Claims (1)
EP 19183702 · Jul 1, 2019 · regional
Continuity (1)
Related Publication 20220356364A1 · Nov 10, 2022
Cited By (2)
US 12,582,179 US 12,643,989